App-Quantinova.ai

Unsupervised Classification of Multiparametric MRI Correlates with Red Blood Cell, Fibrin and Collagen Content in Murine Model of Venous Thrombosis

O.R. Palmer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Mode of Anaesthesia Influences Outcome in Mouse Models of Arterial Thrombosis

M. Sashindranath - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

eptifibatide

Linking the Anti‐inflammatory and Anticoagulant Properties, the Natural Inhibitor EcTI Impairs the Physiopathological Aspects of Thrombosis

B. Salu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Rose bengal sodium

Development of a Laser‐induced Thrombosis Model with Improved Reproducibility Allows Detailed Analysis of Dose‐response Effects of Antithrombotic Drugs

P. Larsson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Sickle Cell Trait Accelerates Fibrin Formation and Resistance to Fibrinolysis in Mice and Humans

A. Ilich - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

PLXDC2, a Novel Player of the Coagulation Cascade: Results from a Genome Wide Association Study on Plasma FV Levels

F. Thibord - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Polyphosphate‐induced Thrombosis is Enhanced in Mice Deficient in Histidine‐rich Glycoprotein

R. Malik - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Increased Platelet Contribution to Clot Strength in Cirrhotic Patients with Non‐malignant Recent Portal Vein Thrombosis

E. Scarlatescu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

ADAMTS‐13 and von Willebrand Factor Involved in Portal Vein Thrombosis Development in Cirrhotic Patients

M. Sacco - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Venous thrombosis

N/A

Thrombosis Initiation Examined through a Flexible 3D non‐Newtonian Computational Framework

S.R. Lynch - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Are Global Coagulation Assays Better Measures of the Intensity of Anticoagulation in Patients with Antiphospholipid Syndrome?

W.H. Wong - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Evithrom

An SFMC and D‐d Level According to Each Japanese Generation (Above 50 Years Old)

K. Kawasugi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Warfarin

Accuracy of DOASENSE Dipstick for Assessing Patients Treated Peri‐operatively with DOACs ‐ A Pilot Study

A.J. Tafur - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Assessment of Validated Risk Assessment Models and a Biomarker Ubiquitous in Routine Clinical Care to Identify Hospitalized Medical Patients at Risk for 90‐day Post‐discharge Venous Thromboembolism

S. Woller - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Antiphospholipid Antibodies and Thrombosis in BCR‐ABL Negative Myeloproliferative Neoplasms

R. Dambrauskiene - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Comparative Benefit of Adding a Biomarker Ubiquitously Available in Clinical Care to Validated Risk Assessment Models for the Identification of Hospitalized Medical Patients at Risk for 90‐day Hospital‐associated Venous Thromboembolism

S. Woller - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

To Describe D‐Dimer Levels in Patients Receiving Direct Oral Anticoagulants with and without Suspected Recurrence of Venous Thromboembolism

P. Leung - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

No Change in Coagulation Factor Levels after Knee Arthroscopy

C.E. Touw - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Fibrinogen (IV)

Integrated GWAS and Gene Expression Data Identifies ORM1 as Potential Regulator of Plasma Cell‐free DNA Levels in Families of the GAIT2 Project

S. Lpez - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Thrombin Generation in Patients with Lower‐leg Trauma or Knee Arthroscopy

C. Touw - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Evithrom

Filters

7277 Abstracts